Abstract

ObjectivesA subset of non-functioning pituitary macroadenomas (NFPAs) may exhibit early progression/recurrence (P/R) after surgical resection. The purpose of this study was to apply radiomics in predicting P/R in NFPAs.MethodsOnly patients who had undergone preoperative MRI and postoperative MRI follow-ups for more than 1 year were included in this study. From September 2010 to December 2017, 50 eligible patients diagnosed with pathologically confirmed NFPAs were identified. Preoperative coronal T2WI and contrast-enhanced (CE) T1WI imaging were analyzed by computer algorithms. For each imaging sequence, 32 first-order features and 75 texture features were extracted. Support vector machine (SVM) classifier was utilized to evaluate the importance of extracted parameters, and the most significant three parameters were used to build the prediction model. The SVM score was calculated based on the three selected features.ResultsTwenty-eight patients exhibited P/R (28/50, 56%) after surgery. The median follow-up time was 38 months, and the median time to P/R was 20 months. Visual disturbance, hypopituitarism, extrasellar extension, compression of the third ventricle, large tumor height and volume, failed optic chiasmatic decompression, and high SVM score were more frequently encountered in the P/R group (p < 0.05). In multivariate Cox hazards analysis, symptoms of sex hormones, hypopituitarism, and SVM score were high risk factors for P/R (p < 0.05) with hazard ratios of 10.71, 2.68, and 6.88. The three selected radiomics features were T1 surface-to-volume radio, T1 GLCM-informational measure of correlation, and T2 NGTDM-coarseness. The radiomics predictive model shows 25 true positive, 16 true negative, 6 false positive, and 3 false negative cases, with an accuracy of 82% and AUC of 0.78 in differentiating P/R from non-P/R NFPAs. For SVM score, optimal cut-off value of 0.537 and AUC of 0.87 were obtained for differentiation of P/R. Higher SVM scores were associated with shorter progression-free survival (p < 0.001).ConclusionsOur preliminary results showed that objective and quantitative MR radiomic features can be extracted from NFPAs. Pending more studies and evidence to support the findings, radiomics analysis of preoperative MRI may have the potential to offer valuable information in treatment planning for NFPAs.

Highlights

  • Pituitary adenomas constitute 10–15% of all intracranial tumors [1], the majority being non-functioning pituitary adenomas [2, 3]

  • Hypopituitarism, extrasellar extension, compression of the third ventricle, large tumor height and volume, failed optic chiasmatic decompression, and high Support vector machine (SVM) score were more frequently encountered in the progression/ recurrence (P/R) group (p < 0.05)

  • The radiomics predictive model shows 25 true positive, 16 true negative, 6 false positive, and 3 false negative cases, with an accuracy of 82% and AUC of 0.78 in differentiating P/R from non-P/R Non-functioning pituitary macroadenomas (NFPAs)

Read more

Summary

Introduction

Pituitary adenomas constitute 10–15% of all intracranial tumors [1], the majority being non-functioning pituitary adenomas [2, 3]. The most common presentation is the macroadenoma, which is defined as a tumor larger than 10 mm in size. Non-functioning pituitary macroadenomas (NFPAs) may cause bitemporal hemianopia resulting from optic chiasm compression due to mass effect. Hypopituitarism is observed in some patients due to tumor compression of normal pituitary glandular tissue. More than 90% of NFPAs are diagnosed as benign tumors, 25–55% of these tumors may undergo early progression/ recurrence (P/R) after surgical resection [5,6,7,8]. Adjuvant radiotherapy (RT) is implemented in some institutions in attempts to minimize postoperative P/R in NFPAs, this approach may result in progressive pituitary insufficiency and other longterm complications [10]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call